SMIM19
geneOn this page
Summary
SMIM19 (small integral membrane protein 19, HGNC:25166) is a protein-coding gene on chromosome 8p11.21, encoding Small integral membrane protein 19 (Q96E16).
Predicted to be located in membrane.
Source: NCBI Gene 114926 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 25 total
- MANE Select transcript:
NM_001135674
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25166 |
| Approved symbol | SMIM19 |
| Name | small integral membrane protein 19 |
| Location | 8p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000176209 |
| Ensembl biotype | protein_coding |
| Entrez | 114926 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 18 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000414154, ENST00000416469, ENST00000417410, ENST00000438528, ENST00000490331, ENST00000498447, ENST00000518574, ENST00000529505, ENST00000908389, ENST00000908390, ENST00000908391, ENST00000908392, ENST00000908393, ENST00000908394, ENST00000908395, ENST00000908396, ENST00000908397, ENST00000926900, ENST00000926901, ENST00000966126
RefSeq mRNA: 5 — MANE Select: NM_001135674
NM_001135674, NM_001135675, NM_001135676, NM_001363186, NM_138436
CCDS: CCDS6133
Canonical transcript exons
ENST00000417410 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001660557 | 42541585 | 42542373 |
| ENSE00003572162 | 42548656 | 42548780 |
| ENSE00003613896 | 42546469 | 42546606 |
| ENSE00003901524 | 42552544 | 42555195 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 98.94.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 36.6761 / max 271.7269, expressed in 1819 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 88691 | 32.1870 | 1819 |
| 88692 | 2.1308 | 1235 |
| 88690 | 1.7714 | 1107 |
| 205172 | 0.1765 | 58 |
| 205171 | 0.1489 | 46 |
| 88694 | 0.1370 | 42 |
| 88695 | 0.0727 | 17 |
| 88693 | 0.0518 | 14 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| parotid gland | UBERON:0001831 | 98.94 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 98.27 | gold quality |
| bronchial epithelial cell | CL:0002328 | 98.24 | gold quality |
| kidney epithelium | UBERON:0004819 | 98.20 | gold quality |
| tibialis anterior | UBERON:0001385 | 98.14 | gold quality |
| bronchus | UBERON:0002185 | 97.95 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.70 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 97.64 | gold quality |
| upper arm skin | UBERON:0004263 | 97.56 | gold quality |
| deltoid | UBERON:0001476 | 97.54 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 97.51 | gold quality |
| vastus lateralis | UBERON:0001379 | 97.49 | gold quality |
| myocardium | UBERON:0002349 | 97.34 | gold quality |
| biceps brachii | UBERON:0001507 | 97.28 | gold quality |
| ileal mucosa | UBERON:0000331 | 97.07 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 96.88 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.86 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 96.86 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 96.84 | gold quality |
| quadriceps femoris | UBERON:0001377 | 96.64 | gold quality |
| body of pancreas | UBERON:0001150 | 96.52 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 96.46 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 96.28 | gold quality |
| tendon | UBERON:0000043 | 96.26 | gold quality |
| right uterine tube | UBERON:0001302 | 96.13 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.13 | gold quality |
| muscle tissue | UBERON:0002385 | 96.11 | gold quality |
| upper leg skin | UBERON:0004262 | 96.07 | gold quality |
| skin of hip | UBERON:0001554 | 96.06 | gold quality |
| corpus epididymis | UBERON:0004359 | 95.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting SMIM19, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-1324 | 99.46 | 66.57 | 1302 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-1206 | 99.30 | 69.32 | 1016 |
| HSA-MIR-1273H-3P | 99.29 | 67.55 | 980 |
| HSA-MIR-6809-5P | 99.13 | 68.45 | 1223 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-1304-3P | 98.29 | 66.44 | 1207 |
| HSA-MIR-3166 | 98.24 | 66.63 | 1223 |
| HSA-MIR-432-5P | 98.00 | 68.13 | 989 |
| HSA-MIR-450A-2-3P | 97.91 | 67.56 | 1459 |
| HSA-MIR-6807-5P | 97.51 | 64.25 | 1046 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | smim19 | ENSDARG00000037423 |
| mus_musculus | Smim19 | ENSMUSG00000031534 |
| rattus_norvegicus | Smim19 | ENSRNOG00000024930 |
Protein
Protein identifiers
Small integral membrane protein 19 — Q96E16 (reviewed: Q96E16)
All UniProt accessions (3): E5RII4, E5RKA7, Q96E16
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the SMIM19 family.
RefSeq proteins (5): NP_001129146, NP_001129147, NP_001129148, NP_001350115, NP_612445 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029368 | SMIM19 | Family |
Pfam: PF15117
UniProt features (2 total): chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96E16-F1 | 68.02 | 0.11 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 70 (showing top):
E4F1_Q6, RYTTCCTG_ETS2_B, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, MARTENS_TRETINOIN_RESPONSE_DN, PEDRIOLI_MIR31_TARGETS_DN, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, PCGF1_TARGET_GENES, SUPT16H_TARGET_GENES, ZNF618_TARGET_GENES, MIR7154_5P, MIR589_3P, MIR2110, MIR433_3P, GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
234 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMIM19 | OR8B12 | Q8NGG6 | 571 |
| SMIM19 | OR8B3 | Q8NGG8 | 528 |
| SMIM19 | ZNF484 | Q5JVG2 | 514 |
| SMIM19 | A0A2U3TZT1 | A0A2U3TZT1 | 506 |
| SMIM19 | ANKMY2 | Q8IV38 | 448 |
| SMIM19 | TBATA | Q96M53 | 435 |
| SMIM19 | SMIM9 | A6NGZ8 | 432 |
| SMIM19 | TBC1D8B | Q0IIM8 | 431 |
| SMIM19 | SETD9 | Q8NE22 | 420 |
| SMIM19 | C10orf90 | Q96M02 | 400 |
| SMIM19 | NXNL1 | Q96CM4 | 386 |
| SMIM19 | EME2 | A4GXA9 | 379 |
| SMIM19 | DENND5B | Q6ZUT9 | 377 |
| SMIM19 | CPNE8 | Q86YQ8 | 370 |
| SMIM19 | KIF12 | Q96FN5 | 366 |
| SMIM19 | SLC20A2 | Q08357 | 366 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UBQLN2 | SMIM19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | SMIM19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GET3 | SMIM19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASPH | SMIM19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| JAGN1 | SMIM19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM19 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMIM19 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| JAGN1 | SMIM19 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): SMIM19 (Two-hybrid), SMIM19 (Two-hybrid), UBQLN2 (Two-hybrid), ASNA1 (Two-hybrid), ASPH (Two-hybrid), SMIM19 (Proximity Label-MS), SMIM19 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GQX3, A0A1B0GRQ0, A0A1B0GV90, A4D0T7, A4QNL6, A6NFZ4, A9RA88, B0CMA4, B3DHH5, C0HJJ0, C1PGW0, D3YUK8, F2Z3Y9, F5HFG3, G1TZA0, G2TRP0, O13001, O14068, O39920, P0DKX4, P34535, P57054, P61807, P61808, Q06FW7, Q19443, Q3E8L0, Q3E912, Q3T0S0, Q4V921, Q54L98, Q5F3W2, Q5R687, Q5RBD8, Q5U4Q2, Q66J27, Q6PQZ3, Q80UA9, Q80ZU4, Q8AUU1
Diamond homologs: A4QNL6, A5D7B5, Q4V921, Q5RBD8, Q80ZU4, Q96E16
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
799 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:42541222:T:TA | donor_gain | 1.0000 |
| 8:42548777:ATTT:A | donor_gain | 1.0000 |
| 8:42548778:TTT:T | donor_gain | 1.0000 |
| 8:42548781:G:GG | donor_gain | 1.0000 |
| 8:42552532:T:A | acceptor_gain | 1.0000 |
| 8:42552535:T:A | acceptor_gain | 1.0000 |
| 8:42552537:T:TA | acceptor_gain | 1.0000 |
| 8:42552542:A:AG | acceptor_gain | 1.0000 |
| 8:42552543:G:GG | acceptor_gain | 1.0000 |
| 8:42552630:G:GT | donor_gain | 1.0000 |
| 8:42541824:C:A | donor_gain | 0.9900 |
| 8:42546467:A:AG | acceptor_gain | 0.9900 |
| 8:42546468:G:GA | acceptor_gain | 0.9900 |
| 8:42546468:GC:G | acceptor_gain | 0.9900 |
| 8:42546468:GCC:G | acceptor_gain | 0.9900 |
| 8:42546468:GCCCC:G | acceptor_gain | 0.9900 |
| 8:42546602:AAAAG:A | donor_loss | 0.9900 |
| 8:42546603:AAAG:A | donor_loss | 0.9900 |
| 8:42546604:AAG:A | donor_loss | 0.9900 |
| 8:42546605:AG:A | donor_loss | 0.9900 |
| 8:42546606:GGT:G | donor_loss | 0.9900 |
| 8:42546607:G:A | donor_loss | 0.9900 |
| 8:42546608:T:G | donor_loss | 0.9900 |
| 8:42548639:ATG:A | acceptor_gain | 0.9900 |
| 8:42548776:CATTT:C | donor_gain | 0.9900 |
| 8:42548779:TTGT:T | donor_loss | 0.9900 |
| 8:42548780:TG:T | donor_loss | 0.9900 |
| 8:42548781:G:GC | donor_loss | 0.9900 |
| 8:42548782:TAAGT:T | donor_loss | 0.9900 |
| 8:42548783:A:AT | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000266422 (8:42547336 G>A,C), RS1000973972 (8:42541276 G>A), RS1001026264 (8:42541568 G>A), RS1001058815 (8:42551084 C>T), RS1001286437 (8:42543835 A>G), RS1001316196 (8:42546709 A>G), RS1001402389 (8:42543451 G>T), RS1001584198 (8:42550226 C>T), RS1002469777 (8:42540691 T>C), RS1002700846 (8:42545392 G>A), RS1003078896 (8:42552217 A>C), RS1003313941 (8:42543578 A>G), RS1003415000 (8:42550537 C>T), RS1003747467 (8:42542253 C>A,T), RS1003849503 (8:42542124 G>T)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:213600, MIM:606656
GenCC curated gene-disease
Mondo (1): basal ganglia calcification, idiopathic, 1 (MONDO:0024538)
Orphanet (1): Bilateral striopallidodentate calcinosis (Orphanet:1980)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003854_24 | Gut microbiota (functional units) | 4.000000e-08 |
| GCST004329_1 | Mean corpuscular hemoglobin concentration | 5.000000e-07 |
| GCST004329_2 | Mean corpuscular hemoglobin concentration | 3.000000e-11 |
| GCST010083_246 | Hemoglobin levels | 8.000000e-26 |
| GCST010703_179 | Brain morphology (MOSTest) | 5.000000e-11 |
| GCST90000047_154 | Age at first sexual intercourse | 1.000000e-10 |
| GCST90002384_175 | Hemoglobin | 1.000000e-33 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007874 | gut microbiome measurement |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C537657 | Basal ganglia calcification, idiopathic 2 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 4 |
| GSK-J4 | decreases expression | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| pyrachlostrobin | decreases expression | 1 |
| picoxystrobin | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Ketoconazole | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Smoke | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| tert-Butylhydroperoxide | affects expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): basal ganglia calcification, idiopathic, 1